Cargando…

Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma

BACKGROUND: The aberrant regulation of cell cycle is significantly correlated with cancer carcinogenesis and progression, in which cell cycle checkpoints control phase transitions, cell cycle entry, progression, and exit. However, the integrative role of cell cycle checkpoint-related genes (CRGs) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Wei-Wei, Guan, Jing-Zhi, Long, Ya-Ping, Song, Qi, Xiong, Qi, Qin, Bo-Yu, Ma, Zhi-Qiang, Hu, Yi, Yang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404245/ https://www.ncbi.nlm.nih.gov/pubmed/36033441 http://dx.doi.org/10.3389/fonc.2022.915662

Ejemplares similares

Efficacy and Safety of Immune Checkpoint Inhibitor in Advanced Esophageal Squamous Cell Carcinoma: A Meta-Analysis
por: Gu, Yi-Min, et al.
Publicado: (2021)

Editorial: Radiomics Advances Precision Medicine
por: Gao, Bo, et al.
Publicado: (2022)

Study Progress of Radiomics With Machine Learning for Precision Medicine in Bladder Cancer Management
por: Ge, Lingling, et al.
Publicado: (2019)

Study Processes and Applications of Ultrasomics in Precision Medicine
por: Yin, Rui, et al.
Publicado: (2020)

The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
por: Girard, Antoine, et al.
Publicado: (2020)

Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer
por: Zhao, Yang, et al.
Publicado: (2021)

Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma
por: Xia, Qi-Dong, et al.
Publicado: (2023)

Artificial intelligence assists precision medicine in cancer treatment
por: Liao, Jinzhuang, et al.
Publicado: (2023)

Editorial: Precision Medicine and Translational Research in Urological Oncology
por: Na, Rong, et al.
Publicado: (2022)

Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective
por: Yang, Yongjun, et al.
Publicado: (2023)

Role of NRP1 in Bladder Cancer Pathogenesis and Progression
por: Dong, Yang, et al.
Publicado: (2021)

Molecular Profiling–Based Precision Medicine in Cancer: A Review of Current Evidence and Challenges
por: Zhang, Qi, et al.
Publicado: (2020)

Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis
por: Wang, Chengyuan, et al.
Publicado: (2020)

Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma
por: Teng, Zhi-Hai, et al.
Publicado: (2022)

Integrative analysis of triphenyl phosphate: contextual interpretation of bladder cancer cohort
por: Zhang, Xiaolei, et al.
Publicado: (2023)

The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment
por: Gong, Lanqi, et al.
Publicado: (2021)

Editorial: Precision Medicine in Oncology
por: Re, Angela, et al.
Publicado: (2018)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

Association of Lymphocyte-to-Monocyte Ratio With Survival in Advanced Gastric Cancer Patients Treated With Immune Checkpoint Inhibitor
por: Chen, Yang, et al.
Publicado: (2021)

Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer
por: El Ahanidi, Hajar, et al.
Publicado: (2022)

Risk of Pneumonitis Associated With Immune Checkpoint Inhibitors in Melanoma: A Systematic Review and Network Meta-Analysis
por: Sun, You-Meng, et al.
Publicado: (2021)

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer
por: Peng, Mou, et al.
Publicado: (2021)

Applications of Circulating Tumor DNA in Immune Checkpoint Inhibition: Emerging Roles and Future Perspectives
por: Lu, Chang, et al.
Publicado: (2022)

Precision Interventional Brachytherapy: A Promising Strategy Toward Treatment of Malignant Tumors
por: He, Pan, et al.
Publicado: (2021)

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
por: Xiong, Wei, et al.
Publicado: (2021)

Deep Genomic Sequencing of Bladder Urothelial Carcinoma in Southern Chinese Patients: A Single-Center Study
por: Li, Dong-Yang, et al.
Publicado: (2021)

Knockdown of NAA25 Suppresses Breast Cancer Progression by Regulating Apoptosis and Cell Cycle
por: Xu, Jingkai, et al.
Publicado: (2022)

Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction
por: Lyu, Xiaoyue, et al.
Publicado: (2022)

Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy
por: Wu, Jie, et al.
Publicado: (2021)

Precision Medicine in Lymphoma by Innovative Instrumental Platforms
por: Di Paolo, Antonello, et al.
Publicado: (2019)

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis
por: Tang, Xi-Yang, et al.
Publicado: (2021)

Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study
por: Jin, Di, et al.
Publicado: (2020)

Efficacy and safety of PD-1/PD-L1 inhibitor combined with chemotherapy versus chemotherapy alone in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis
por: Liu, Bo-Wei, et al.
Publicado: (2023)

Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway
por: Qin, Zhen-Qi, et al.
Publicado: (2020)

Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
por: Ramroop, Johnny R., et al.
Publicado: (2018)

Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018)

Global Inequities in Precision Medicine and Molecular Cancer Research
por: Drake, Thomas M., et al.
Publicado: (2018)

A New Era of Prostate Cancer Precision Medicine
por: Malik, Adil, et al.
Publicado: (2019)

Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
por: Wang, Wanyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nnrlbmu490n40v9tdq0r40itl3